Search This Blog

Thursday, June 4, 2020

Europe Re-Opens Schools – Suffers No Second COVID Wave

Ahead of the fall academic year, American parents are asking one question: If schools reopen, will my child be safe from COVID-19
Well, there’s some good news from Europe in the last several weeks. The Wall Street Journal has compiled a list of officials from countries who have overwhelmingly reported, that after a month or so of having education systems open, there are limited to no outbreaks of the virus.
Schools in Denmark, Austria, Norway, Finland, and Germany, have been operating for 1-2 months with no issue whatsoever about the virus. This is excellent news for American parents but also for stubborn US education officials who continue to shutter many school systems across the country for the upcoming academic year.
Denmark was one of the first Western countries to reopen schools in mid-April and has a tracing system for if an outbreak is detected.
“Our interpretation is that it may be that the children aren’t that important for the spread of infection,” said Tyra Grove Krause, a senior official with the State Serum Institute. Schools have imposed social distancing, air circulation, and new hygiene measures to reduce transmission risk.
Norweigan Education Minister Guri Melby said if infections rise in the country, education facilities will remain open. Melby reopened schools on April 20 and has yet to report any significant outbreak.
Austria reopened on May 18, so far, there has been no rise in infections at schools and kindergartens, a government spokesman said.
Schools in Germany have been opened for at least a month, with no increase in cases. However, cases have surged at migrant shelters, slaughterhouses, restaurants, and churches, while schools have been widely spared.
Finland opened schools on May 14, Mika Salminen, director of health security at the Finnish Institute of Health and Welfare, recently said, adding that no new cases have been reported at any schools and or day-care centers.
Professor Herman Goossens, a medical microbiologist, and coordinator of the European Union, said the main reason for no outbreaks at schools is because children have fewer ACE2 receptors the virus uses to enter the body.
Goossens said data from around the world showed children accounted for less than 1% of total infections.
Though German Health Minister Jens Spahn recently warned that “the state of science at the moment doesn’t allow for any real conclusions about how much children contribute to the spread of the virus…. There are different assessments, and that makes it especially difficult to make political decisions.”
It appears that children are less susceptible to contracting the virus. Maybe it’s time to reopen America’s schools… The longer schools are shut — the more protesting and rioting from millennials will be seen.
https://www.zerohedge.com/health/europe-re-opens-schools-suffers-no-second-covid-wave

India’s top bureaucrats hit by coronavirus as cases spike

A top Indian civilian defence official has tested positive for coronavirus and is in home quarantine, government officials said on Thursday, as the daily rise in infections hits a new high.
India’s cases reached 216,919 after 9,304 new cases were reported over the previous day, the health ministry said. The densely packed cities of Delhi and Mumbai are seeing a spike in infections as the government lifts a lockdown imposed in March.
India has reported 6,075 deaths due to the virus.
Defence Secretary Ajay Kumar is the highest ranking official to have tested positive for the virus that has also affected officials in the finance, foreign and law ministries based in a sprawling set of buildings in central Delhi.
Defence Minister Rajnath Singh, leading the response to an ongoing military standoff with China at their disputed Himalayan border, worked from home after Kumar’s test results came back positive, a defence source said.

It was not immediately clear if Singh had undergone a test. At least four finance ministry employees have been infected.
About three dozen staff in the defence, finance and law ministries that came in contact with infected staff have been advised to go on mandatory quarantine, the officials said.
“We have asked some of them to go on a compulsory 14-day home quarantine, then they will have to get tested before joining back,” one official said. Meetings in conference rooms have been cancelled and officials have been encouraged to minimise physical interaction.
Some officials at key departments such as national security and foreign affairs continued to work from the office even when the lockdown was first imposed, and more were asked to attend later as the curbs were eased.
Prime Minister Narendra Modi held a virtual summit with his Australian counterpart Scott Morrison from his official residence.

Criticism has grown that Modi’s lockdown of 1.3 billion people has failed to control the epidemic while it destroyed thousands of jobs.
“You have definitely decimated the economy. You flattened the wrong curve. It is not the infection curve, it is the GDP curve. This is what we have ended (up) with, the worst of both worlds,” Rajiv Bajaj, managing director of Bajaj Auto, said.
https://www.reuters.com/article/us-health-coronavirus-india/indias-top-bureaucrats-hit-by-coronavirus-as-cases-spike-idUSKBN23B19R?il=0

Bayer’s dicamba sales blocked by U.S. appeals court

The Ninth U.S. Circuit Court of Appeals blocks Bayer (OTCPK:BAYRY) from selling its dicamba-based herbicide in the U.S., which means farmers who bought seeds to be used with dicamba for this year’s growing season may not be able to plant them and will be forced to absorb the cost.
A three-judge panel concluded today that the Environmental Protection Agency “substantially understated risks” posed by dicamba and that the agency violated federal regulations when it extended its approval of registration for the herbicide for another two years in October 2018.
In addition to Bayer’s Monsanto products, the ruling applies to other dicamba-based herbicides produced by BASF (OTCQX:BASFY) and Corteva Agriscience (NYSE:CTVA).
https://seekingalpha.com/news/3580293-bayers-dicamba-sales-blocked-u-s-appeals-court

Roche’s severe COVID-19 test scores FDA approval

Some COVID-19 patients can develop a severe inflammatory response called a cytokine storm, which can be deadly and pose a high risk of intubation via mechanical ventilation.
As a result, the FDA granted emergency authorization to a blood test from Roche (OTCQX:RHHBY), called Elecsys IL-6, which can pinpoint those most at-risk people early by measuring levels of interleukin 6 in the blood.
Roche also makes one of the most accurate serology tests, which hunts for coronavirus antibodies to identify past infection.
https://seekingalpha.com/news/3580297-roches-severe-covidminus-19-test-scores-fda-approval

AstraZeneca, Accent Therapeutics to develop novel cancer therapies

Accent Therapeutics and AstraZeneca (NYSE:AZN) will collaborate to discover, develop and commercialize transformative therapeutics targeting RNA-modifying proteins for the treatment of cancer.
Under the terms of agreement, Accent will be responsible for research, development and commercialization activities for a nominated preclinical program through to the end of Phase I clinical trials, with the company having the option to jointly develop and commercialize in the US.
Accent will receive an upfront payment of $55M and is eligible for up to ~$1.1B in total additional milestones, plus tiered royalties, under co-development and co-commercialization arrangement.
AstraZeneca will also have the exclusive option to license worldwide rights to two further preclinical discovery programs.
https://seekingalpha.com/news/3580309-astrazeneca-inks-deal-accent-therapeutics-to-develop-novel-cancer-therapeutics

Wednesday, June 3, 2020

Brazil to help test Oxford coronavirus vaccine

An experimental vaccine against the new coronavirus developed at the University of Oxford will be tested from mid-June in Brazil, the first country outside Britain to take part in the study, researchers said Wednesday.
The vaccine will be tested in Brazil on 2,000 volunteers, who will be recruited starting this week, said the Federal University of Sao Paulo, which is coordinating the study.
Volunteers “must be between 18 and 55 years old and be at high risk of infection, for example, cleaning and support staff in units treating COVID-19 patients,” the Brazilian university’s president, Soraya Smaili, told AFP.
Testing the vaccine in Brazil “is very important because we are in the acceleration phase of the epidemiological curve,” she added.
Brazil is the latest epicenter in the coronavirus pandemic.
The country of 210 million people is now second only to the United States in total cases, with more than 555,000, and has registered more than 31,000 deaths, the fourth-highest toll in the world, after the US, Britain and Italy.
Experts say under-testing means the real figures in Brazil are probably much higher.
Testing is due to start in Brazil the second week in June and expand to other countries after that, the university said.
“The results will be fundamental for the vaccine’s approval in the United Kingdom, expected late this year,” it added.
Oxford is partnering with British pharmaceuticals group AstraZeneca to develop and distribute the vaccine, one of several that researchers around the world are racing to test.
https://medicalxpress.com/news/2020-06-brazil-oxford-coronavirus-vaccine.html

Why some older adults remember better than others

Even among healthy people, a faltering memory is often an expected part of aging—but it’s not inevitable.
“Some individuals exhibit remarkable maintenance of memory function throughout late adulthood, whereas others experience significant memory decline. Studying these differences across individuals is critical for understanding the complexities of brain aging, including how to promote resilience and longevity,” said Alexandra Trelle, a postdoctoral research fellow at Stanford University.
Building on studies that have focused on young populations, Trelle and colleagues are investigating memory recall in healthy, older adults as part of the Stanford Aging and Memory Study. In new research, published May 29 in eLife, this team has found that memory recall processes in the brains of older adults can look very similar to those previously observed in the brains of young adults. However, for those seniors who had more trouble remembering, evidence for these processes was noticeably diminished.
By gaining a better understanding of memory function in older adults, these researchers hope to someday enable earlier and more precise predictions of when memory failures signal increased risk for dementia.
A striking similarity
When Anthony Wagner, the Lucie Stern Professor in the Social Sciences at Stanford’s School of Humanities and Sciences, was a at Stanford in the ’90s, he conducted some of the first fMRI studies of memory formation. At that time, state-of-the-art imaging and analysis technologies only allowed measurement of the magnitude of activity from a centimeter-and-a-half section of the brain.
In contrast, the current study measured activity from the whole brain at high-resolution, and analyses not only focused on the magnitude of activity but also on the memory information that is contained in patterns of brain activity.
“It’s exciting to have basic science tools that allow us to witness when a memory is being replayed in an individual mind and to draw on these neural processes to explain why some older adults remember better than others,” said Wagner, who is senior author of the paper. “As a graduate student, I would never have predicted that we would do this kind of science someday.”
In the experiment, 100 participants between the ages of 60 and 82 had their brains scanned as they studied words paired with pictures of famous people and places. Then, during a scanned memory test, they were prompted with words they had seen and asked to recall the associated picture. The memory test was designed to assess one’s ability to remember specific associations between elements of an event, a form of memory that is often disproportionately affected by aging.
In the scans, the researchers observed that the brain processes that support remembering in older adults resemble those in younger populations: when people remember, there is an increase in hippocampal activity—a brain structure long known to be important for remembering events—along with the reinstatement of activity patterns in the cortex that were present when the event was initially experienced. That is, remembering entails neural time travel, replaying patterns that were previously established in the brain.
“It was striking that we were able to replicate this moment-to-moment relationship between hippocampal activity, replay in the cortex, and memory recall, which has previously been observed only in healthy younger adults,” said Trelle, who is lead author of the paper. “In fact, we could predict whether or not an individual would remember at a given moment in time based on the information carried in patterns of brain activity.”
The researchers found that, on average, recall ability declined with age. Critically, however, regardless of one’s age, stronger hippocampal activity and replay in the cortex was linked to better memory performance. This was true not only for the memory test conducted during the scan but also memory tests administered on a different day of the study. This intriguing finding suggests that fMRI measures of brain activity during are tapping into stable differences across individuals, and may provide a window into brain health.
Only the beginning
This research lays the foundation for many future investigations of memory in in the Stanford Aging and Memory Study cohort. These will include work to further detail the process of memory creation and recall, studies of change in memory performance over time, and research that pairs fMRI studies with other kinds of health data, such as changes in brain structure and the build-up of proteins in the brain that are linked to Alzheimer’s disease.
The ultimate aim is to develop new and sensitive tools to identify individuals who are at increased risk for Alzheimer’s disease before significant decline occurs.
“We’re beginning to ask whether individual differences in the ability to mentally travel back in time can be explained by asymptomatic disease that impacts the and predicts future clinical diagnosis,” said Wagner. “We’re hopeful that our work, which requires rich collaborations across disciplines, will inform clinical problems and advance human health.”

Explore further
A child’s brain activity reveals their memory ability

More information: Alexandra N Trelle et al, Hippocampal and cortical mechanisms at retrieval explain variability in episodic remembering in older adults, eLife (2020). DOI: 10.7554/eLife.55335